Patents by Inventor Robert Andrew DAVEY

Robert Andrew DAVEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF MACROPINOCYTOSIS IN PREVENTION AND TREATMENT OF DISEASE
    Publication number: 20180369251
    Abstract: Described herein are pharmaceutical compositions capable of inhibiting vesicle formation and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat pathogenic infections.
    Type: Application
    Filed: August 30, 2018
    Publication date: December 27, 2018
    Inventors: Robert Andrew Davey, Manu Anantpadma
  • Inhibitors of macropinocytosis in prevention and treatment of disease
    Patent number: 10111881
    Abstract: Described herein are pharmaceutical compositions capable of inhibiting vesicle formation and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat pathogenic infections.
    Type: Grant
    Filed: April 4, 2017
    Date of Patent: October 30, 2018
    Assignee: Texas Biomedical Research Institute
    Inventors: Robert Andrew Davey, Manu Anantpadma
  • INHIBITORS OF MACROPINOCYTOSIS IN PREVENTION AND TREATMENT OF DISEASE
    Publication number: 20180161333
    Abstract: Described herein are pharmaceutical compositions capable of inhibiting vesicle formation and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat pathogenic infections.
    Type: Application
    Filed: April 4, 2017
    Publication date: June 14, 2018
    Inventors: Robert Andrew Davey, Manu Anantpadma
  • Method and apparatus for determining treatment region and mitigating radiation toxicity
    Patent number: 9925393
    Abstract: An apparatus for determining a contour of a treatment region in a patient includes a computer processor to receive input regarding a contour of at least one organ-at-risk (OAR) adjacent to the treatment region; receive input regarding an initial contour of the treatment region; predict a radiation toxicity to the at least one OAR based on the contour of the at least one OAR, the initial contour of the treatment region, and a radiation treatment regimen; determine whether the predicted radiation toxicity exceeds a threshold; and determine a contour of the treatment region by iteratively modifying the initial contour of the treatment region, and any subsequent modified contours of the treatment region, until a stopping condition is satisfied. The stopping condition can be a preselected number of iterations or that the predicted radiation toxicity using the contour in place of the initial contour is first calculated is below said threshold.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: March 27, 2018
    Assignees: KABUSHIKI KAISHA TOSHIBA, TOSHIBA MEDICAL SYSTEMS CORPORATION, The Johns Hopkins University
    Inventors: Minoru Nakatsugawa, John Wayne Haller, Robert Andrew Davey, Rachel-Louise Kvertus Koktava, Kosuke Sakaue, Todd McNutt, Harry Quon, Scott Patrick Robertson, Zhi Cheng
  • METHOD AND APPARATUS FOR DETERMINING TREATMENT REGION AND MITIGATING RADIATION TOXICITY
    Publication number: 20170259083
    Abstract: An apparatus for determining a contour of a treatment region in a patient includes a computer processor to receive input regarding a contour of at least one organ-at-risk (OAR) adjacent to the treatment region; receive input regarding an initial contour of the treatment region; predict a radiation toxicity to the at least one OAR based on the contour of the at least one OAR, the initial contour of the treatment region, and a radiation treatment regimen; determine whether the predicted radiation toxicity exceeds a threshold; and determine a contour of the treatment region by iteratively modifying the initial contour of the treatment region, and any subsequent modified contours of the treatment region, until a stopping condition is satisfied. The stopping condition can be a preselected number of iterations or that the predicted radiation toxicity using the contour in place of the initial contour is first calculated is below said threshold.
    Type: Application
    Filed: March 14, 2016
    Publication date: September 14, 2017
    Applicants: KABUSHIKI KAISHA TOSHIBA, TOSHIBA MEDICAL SYSTEMS CORPORATION, THE JOHNS HOPKINS UNIVERSITY
    Inventors: Minoru NAKATSUGAWA, John Wayne HALLER, Robert Andrew DAVEY, Rachel-Louise Kvertus KOKTAVA, Kosuke SAKAUE, Todd MCNUTT, Harry QUON, Scott Patrick ROBERTSON, Zhi CHENG